United States · FDA National Drug Code directory
BRINZOLAMIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24208-464_1cebefb6-a5b0-e963-e063-6294a90a434f
- Product NDC
- 24208-464
- Form
- SUSPENSION/ DROPS
- Composition / generic term
- brinzolamide
- Labeler
- Bausch & Lomb Incorporated
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220331
- Source listing expiry
- 20261231
Source-listed ingredients
- BRINZOLAMIDE — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (24208-464-10) / 10 mL in 1 BOTTLE, PLASTIC · 24208-464-10
- 1 BOTTLE, PLASTIC in 1 CARTON (24208-464-15) / 15 mL in 1 BOTTLE, PLASTIC · 24208-464-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →